Virpax Pharmaceuticals Correlations

Delisted . USA . 
Stock . Virpax Pharmaceuticals
VRPXDelisted Stock  USD 0.25  0.04  19.05%   
The current 90-days correlation between Virpax Pharmaceuticals and MetaVia is -0.07 (i.e., Good diversification). The correlation of Virpax Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Virpax Pharmaceuticals Correlation With Market

Good diversification

The correlation between Virpax Pharmaceuticals and DJI is -0.08 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Virpax Pharmaceuticals and DJI in the same portfolio, assuming nothing else is changed.
  
The ability to find closely correlated positions to Virpax Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Virpax Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Virpax Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Virpax Pharmaceuticals to buy it.

Moving together with Virpax Pink Sheet

  0.8MBRX Moleculin BiotechPairCorr
  0.65EQ EquilliumPairCorr
  0.67VALN Valneva SE ADRPairCorr
  0.77VCYT VeracytePairCorr
  0.67MLEC Moolec Science SAPairCorr
  0.71DRMA Dermata TherapeuticsPairCorr
  0.84DRUG Bright Minds BiosciencesPairCorr
  0.65CDIOW Cardio DiagnosticsPairCorr
  0.65DTIL Precision BioSciencesPairCorr
  0.82MNKD MannKind CorpPairCorr
  0.83MNOV MediciNovaPairCorr
  0.66MOLN Molecular PartnersPairCorr

Moving against Virpax Pink Sheet

  0.88VANI Vivani MedicalPairCorr
  0.75MGTX MeiraGTx Holdings PLCPairCorr
  0.66MEIP MEI Pharma TrendingPairCorr
  0.63MCRB Seres TherapeuticsPairCorr
  0.6MBIO Mustang BioPairCorr
  0.41MDWD MediwoundPairCorr
  0.4DOMH Dominari HoldingsPairCorr
  0.92MIRM Mirum PharmaceuticalsPairCorr
  0.91VERV Verve TherapeuticsPairCorr
  0.88MLTX MoonLake ImmunotherapeutiPairCorr
  0.79MIST Milestone PharmaceuticalsPairCorr
  0.72DRTS Alpha Tau MedicalPairCorr
  0.7SABSW SAB BiotherapeuticsPairCorr
  0.64VERU Veru IncPairCorr
  0.83MRVI Maravai LifesciencesPairCorr
  0.81MRKR Marker TherapeuticsPairCorr
  0.79VIGL Vigil Neuroscience Sell-off TrendPairCorr
  0.74MRNA ModernaPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
RNXT
+ 0.9
QNRX
RNXT
+ 0.88
NRXP
NRXP
+ 0.84
QNRX
NAOV
+ 0.78
KTTA
NAOV
+ 0.66
INDP
MDIA
+ 0.57
NRXP
  
High negative correlations   
NAOV
- 0.92
QNRX
NAOV
- 0.9
RNXT
NAOV
- 0.83
NRXP
RNXT
- 0.8
KTTA
NRXP
- 0.79
KTTA
QNRX
- 0.75
KTTA

Risk-Adjusted Indicators

There is a big difference between Virpax Pink Sheet performing well and Virpax Pharmaceuticals Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Virpax Pharmaceuticals' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

Virpax Pharmaceuticals Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Virpax Pharmaceuticals pink sheet to make a market-neutral strategy. Peer analysis of Virpax Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Virpax Pharmaceuticals by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Virpax Pharmaceuticals Corporate Management

CPA CPACFO SecProfile
Jeffrey MDChief VPProfile
JD MBAChief OfficerProfile
Usama ChaudhryChief OfficerProfile
Shana PanzarellaChief StaffProfile
Anthony MBAChairman CEOProfile

Still Interested in Virpax Pharmaceuticals?

Investing in delisted pink sheets can be risky, as the pink sheet is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2025 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY